Virtu Financial Stock News

Within the last quarter, Virtu Financial (NASDAQ:VIRT) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 1 1 0 Last

Upgrades For CME Group Inc (NASDAQ:CME), Deutsche Bank upgraded the previous rating of Hold to Buy. In the second quarter, CME Group showed an EPS of $1.97, compared to $1.64 from the year-ago quarte

Virtu Financial (NASDAQ:VIRT) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 1 1 0 Last

Regulators' recent announcement has shareholders breathing a sigh of relief.

Regulators' recent announcement has shareholders breathing a sigh of relief.

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of financial services and products that leverage cutting-edge technology to deliver innovative, tr

NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (Nasdaq:VIRT), a leading provider of financial services and products that leverage cutting-edge technology to deliver innovative, tran

NEW YORK, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT), is a leading provider of financial services and products that leverages cutting-edge technology to deliver innovativ

NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NASDAQ: VIRT), a leading provider of financial services and products that leverage cutting-edge technology to deliver innovative,

Virtu is one of the largest market making firms in the marketplace. Market making can often benefit during volatile markets, as bid/ask spreads are wider.

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's

Shares of market maker Virtu Financial surged Thursday following a report from Bloomberg that the U.S. Securities and Exchange Commission will refrain from banning payment for order flow.

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, t

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording gains in today’s session. Albireo Pharma, Inc. (NASDAQ: ALBO) surged 13% to $

Shares of Robinhood surged Thursday following a report from Bloomberg that the U.S. Securities and Exchange Commission will refrain from banning payment for order flow.